MARATTO

article · Zenodo (CERN European Organization for Nuclear Research)

Artocarpus Heterophyllus Lam. (Moraceae): Phytochemistry, Pharmacology And Future Directions, A Mini-Review

201714 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

The aim of this mini-review was to collect data obtained from various studies carried out by different authors concerning the phytochemistry and pharmacognosy of <em>Artocarpus heterophyllus</em> Lam. This review has been compiled using references from major databases such as PubMed, PubMed Central, Science Direct and Google scholar. An extensive survey of literature revealed that <em>Artocarpus heterophyllus</em> Lam. is a good source of health promoting secondary metabolites such as flavonoids, terpenoids, steroids, phenols, prenylflavones, glycosides, saponins, alkaloids and tannins. Due to the presence of these metabolites, this species may have wonderful applications (like anthelminthic properties).The bark, roots, leaves, and fruit are attributed with diverse medicinal properties and are used in various traditional and folk systems of medicine to treat a range of ailments. This plant possesses antioxidant, anti-inflammatory, antibacterial, anticariogenic, antifungal, antineoplastic, hypoglycemic properties and many others. The results of this review make <em>A. heterophyllus </em>an interesting candidate for advanced anthelminthic properties.

Research topics

  • Bioactive natural compounds
  • Natural Antidiabetic Agents Studies
  • Natural product bioactivities and synthesis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5281/zenodo.1019850

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.